Celebrex Total Knee Arthroplasty Study

NCT00359151 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated early due to slow enrollment.

Conditions

Osteoarthritis
Pain

Interventions

DRUG: Celecoxib
DRUG: Placebo

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.